The CLDN18.2 (Zolbetuximab Biosimilar) Antibody (HDbs0069) is a valuable tool for researchers studying CLDN18.2, a tight junction protein involved in maintaining epithelial barrier integrity. This monoclonal antibody, produced in mice, exhibits high specificity and sensitivity for detecting CLDN18.2 in various samples, making it suitable for use in immunohistochemistry and flow cytometry applications.CLDN18.2 is known to be overexpressed in certain cancers, particularly gastric cancer, where it serves as a potential therapeutic target.
By targeting CLDN18.2, researchers can investigate the role of this protein in cancer progression and explore novel treatment strategies. The Anti-CLDN18.2 Antibody (HDbs0069) provides researchers with a reliable tool for investigating the biological function of CLDN18.2 and its potential as a target for precision medicine approaches in cancer therapy.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
GC-182,IMAB-362,IMAB362,claudiximab
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
system_update_altDatasheetBCMA Biosimilar Antibody (HDBS0016)The Anti-BCMA Monoclonal Antibody (HDbs0016) is a cutting-edge tool developed for researchers working in the f
system_update_altDatasheetMagrolimab Biosimilar, Igg1 Biosimilar (CD47) Antibody (HDBS0049)The CD47 Magroli Biosimilar (HDBS0049) is a cutting-edge product developed by As
